Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Clinical trial NCT00473824 · TERMINATED

Trial details

NCT number: NCT00473824
Sponsor: ADMA Biologics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sequelae of Viral Hepatitis Transplantation Infection Evidence of Liver Transplantation

Start date: 2007-05-01
Primary completion: 2009-02-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.